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“Our virtues and our failures are inseparable, like force and matter. When 
they separate, man is no more.” 
 
 
                                              - Nicola Tesla 
  
 
 
 
  
 
 
 
 
Antibacterial surfaces for biomedical applications 
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ABSTRACT 
Medical devices such as orthopedic implants are intended to serve for improved quality of life. 
However, clinical success cannot be taken for granted and the most common reason for failure 
is due to biomaterials associated infection (BAI). An implantation surgical site is a susceptible 
environment for bacterial colonization, which in combination with compromised immune 
system, results in that bacteria can develop biofilms on the implant surface or in adjacent tissue. 
Once such a biofilm has established, it may lead to an infection that cannot be eradicated by 
means of traditional antibiotics, often resulting in revision surgery. Wounds after post 
implantation surgery is another risk for bacterial colonization into underlying tissue and 
increases further the susceptibility to infection. These and other bacteria related complications 
are today becoming more serious due to the rapid increase of antibiotic resistance worldwide. 
This has resulted in that many available antibiotics are losing their potency against bacteria and 
consequently, treating an infection with antibiotics is not working as effectively as in the past. 
The objective of this thesis was to find new solutions to address the complications associated 
with bacterial colonization through applying preventive measures by designing antibacterial 
surfaces for inhibition of early biomaterials associated and wound infection. For this purpose, 
two types of antibacterial surfaces were designed and evaluated. In the first type, a local drug-
delivery system based on mesoporous titania thin film was developed. This film was to serve 
as implant coating where antibiotics are released locally at the implantation site to prevent 
biofilm formation and subsequent tissue colonization. In the second approach, antibacterial 
surfaces were developed through covalent immobilization of a cationic antimicrobial peptide 
(AMP), thus creating surfaces that kill bacteria upon contact. 
The overall results in this thesis, which are presented as four papers, suggest that the developed 
antibacterial surfaces are promising to use in future biomedical applications. 
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1 A big problem 
 
 
 “If we don’t act now, our medicine cabinet will be empty, and we won’t have 
the antibiotics we need to save lives.” 
                                                                           Center for disease control (CDC) Director, Tom Frieden 
 
 
 
 
 
What does a world without antibiotics mean to us? Can we imagine a world where many 
millions of women dying in child birth, impossible chemotherapy treatments for cancer 
patients, no organ transplant, no routine surgeries and small wounds turning into life threatening 
conditions? 
Today, we are standing on the edge of a post-antibiotic era, a dreadful scenario where antibiotics 
are not efficient anymore and simple infections can become mortal. Although the seriousness 
of the antibiotic resistance problem is pointed out repeatedly by international public health 
institutes such as World Health Organization (WHO), there is still a constant tension between 
the necessity of using antibiotics to cure an infection and the adverse outcome of their use which 
is developing resistance by bacteria. Antibiotic resistance occurs when bacteria that are exposed 
to antibiotics, in an evolutionary process, develop genes encoding resistance and pass them 
along to create a full generation of resistant microbes. This problem is progressing so rapidly 
that UN has called it a “global health emergency”. In order to fight the war against antibiotic 
resistance, we need immediate actions. Antibiotic resistance should be stopped before it 
becomes a real crisis and before a big population gets affected. 
Believing that one of the most effective ways to reduce antibiotic resistance is a reduction in 
the use of antibiotics lies behind the motivation of this thesis, that is, to introduce new solutions 
to stop or decrease unnecessary usage of antibiotics linked to implant surgeries or wound 
management routines.  
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2 Introduction 
 
“Good health is a temporary condition” as physiatrists say. Although natural healing processes 
and defense immune system helps the human body to heal from a variety of illnesses and 
injuries by its own, at some point, it will face serious health conditions that need advanced 
healthcare solutions to help its healing process along.  For instance, over the past decades the 
demand for medical implants and devices has considerably increased in order to help restore 
organ failures that arise from chronic diseases, aging population and traumas.1 However, one 
major complexity of using medical implants, is the elevated risk of infection.2 Bacterial 
colonization of biomaterial surfaces and surrounding tissues in combination with a comprised 
immune system, undermines the intended performance of biomaterials.3,4 In addition, most 
surgical procedures that are performed to insert implants leave a surgical wound. A wound itself 
creates a susceptible environment for bacterial growth into the damaged skin to generate an 
infection progressing into underlying tissue.5  Today, infections cannot as simple as before be 
treated and eradicated by traditional antibiotic therapy. Patients may endure long-term 
unsuccessful antibiotic therapy sessions and its subsequent systemic side effects result in long 
hospitalization and high cost for healthcare systems.6,7 One reason that complicates the 
infection control associated with biomaterials and chronic wounds is that up to 80% of human 
bacterial infections are biofilm associated and bacteria in biofilm community can escape 
diagnostic procedures, host immune defense and antibiotic therapy.8 Furthermore, the 
emergence of antibiotic resistance is happening worldwide, and the world is entering a post-
antibiotic era where even simple skin infections can become life-threatening. The potency of 
available antibiotics is becoming limited since resistant bacteria no longer respond to many 
available antibiotics.9,10  
For medical devices to improve the quality of human life, and not to expose additional 
complexities to it, the most important step would be to avoid bacterial colonization as the first 
line of defense against infection.11 Adherent bacteria biofilm on a biomaterial surface, is a 
potential source of an infection spreading to surrounding tissue. Due to impairment of the host 
immune response, bacteria can also reside within host cells around the implant and cause 
recurrent infections.4 Prevention of biofilm formation and tissue colonization is therefore the 
main rationale behind extensive efforts in designing and fabricating new generations of 
antibacterial surfaces.12  
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3 Objectives 
 
The main objective of this thesis was to apply preventive strategies in the design of antibacterial 
surfaces for prevention of early biomaterials associated infections and bacterial colonization at 
the wound site. For this purpose, two main types of antibacterial surfaces were designed and 
discussed as shown in Figure 1. 
 
 
 
The goal of the first approach was to create local drug-delivery systems as implant coatings to 
release antibiotics directly at the implantation site and prevent biofilm formation and 
subsequent tissue colonization.  
Paper I and II, each introduce a separate drug-delivery model using mesoporous titania (MPT) 
thin films as antibiotic carriers (Figure 2). Antibacterial performance of MPT thin films with 
variable pore sizes (2-7nm) and their antibiotic loading and release efficacies, driven by solvent 
diffusion, are evaluated in paper I, Figure 2a. While in paper II, MPT is used in a combination 
with a thermoresponsive polymer, PNIPAAm, with incorporated nanorods. This combination 
is designed to create a photon induced controlled release system, Figure 2b.  
 
 
Figure 1. Schematic demonstrating the two types of antibacterial surfaces discussed in this 
thesis. 
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Designing contact killing surfaces, is a second approach presented in this thesis. In this strategy, 
surfaces are modified with covalent immobilization of a cationic antimicrobial peptide (AMP), 
RRPRPRPRPWWWW-NH2, to create surfaces that kill bacteria upon contact, Figure 3.  
In paper III and IV, two substrates for AMP immobilization are introduced. Recombinantly 
synthesized elastin-like polypeptides with cell-adhesive RGD motives were used to combine 
favorable cell properties with antibacterial activities with the aim to create implant coatings that 
enhance tissue integration and prevent biofilm formation. (Figure 3a). A nanostructured 
crosslinked lyotropic liquid crystalline hydrogel made of modified pluronic™ F127 (MF127) 
polymer was applied as a second substrate. Unlike ELP surfaces, MF127 hydrogels do not have 
cell adhesive sites in their structure. Moreover, the amphiphilic nature of such materials is 
speculated to favor attachments of AMPs that are amphiphilic molecules as well. Combined 
with high fluid absorption properties, AMP modification on such substrates can create contact 
killing surfaces suitable for applications such as wound care patches for prevention of wound 
associated infections (Figure 3b).  
 
 
 
 
 
 
 
Figure 2. A schematic of the drug-delivery surfaces used in this thesis. a, Mesoporous titania 
thin films with variable pore sizes used for antibiotic delivery and b, Mesoporous titania thin 
films combined with PNIPAAm polymer coating with incorporated nanorods. 
MPT=mesoporous titania and GNR= gold nanorods 
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Figure 3. A schematic of the contact killing substrates used in this thesis. a, AMP 
immobilization onto recombinant elastin-like polypeptides with RGD sequences and b, AMP 
immobilization onto cross-linked nanostructured F127 hydrogels. 
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4   Background 
 
To provide a more detailed understanding of the choice of materials and design methods used 
in this thesis, a background including two main chapters is presented. Chapter 4.1 introduces 
drug-eluting implant coatings and use of mesoporous titania as antibiotic carriers while chapter 
4.2 focuses on contact-killing surfaces using antimicrobial peptides for biomedical applications 
such as implant coatings and wound care patches. 
 
4.1 Antibiotic eluting surfaces  
 
4.1.1 Local antibiotic delivery  
 
Applying surface coatings that release antibiotics from biomaterials is considered an effective 
strategy to prevent BAI.13 Local antibiotic delivery systems introduce an inbuilt functionality 
to obtain targeted and/or controlled release of antibiotics from biomaterials for prevention of 
infection.14 Local administration of antibiotics that can release the drug directly to the site of 
implantation without the patient having to take systemic doses is a common way to decrease 
the side effects and drug toxicity while maximizing the treatment outcome.15 Moreover, a rapid 
initial release of antibiotics from implant surfaces can be an effective way to prevent the spread 
of bacteria from surfaces to the surrounding tissue.4 However, local antibiotic delivery 
approaches face challenges such as difficulties in controlling the release kinetics with a risk of 
diluting the antibiotic to a concentration below the minimum inhibitory concentration (MIC) 
which makes the treatment ineffective. Most importantly, the duration of drug release must be 
restricted to a limited time period to prevent development of antibiotic resistance.16 
Collectively, such complexities necessitate a careful and practical design of carriers for local 
antimicrobial drug-delivery systems. Recently, the development of nanomaterials has generated 
significant advances in improving local antimicrobial drug-delivery systems.14 For example, 
mesoporous materials have been highlighted within nanomedicine as a promising drug-delivery 
system for their unique characteristics, such as high specific surface area and tunable pore 
size.17,18  
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4.1.2 Mesoporous titania 
 
Over the past decades, the use of mesoporous titania (MPT) has become attractive in various 
application fields including optics, environmental energy systems, electronics, medicines and 
biomaterials.19,20 High surface area, tunable pore size (2-50 nm) and morphology as well as 
being environmentally friendly and biocompatible are favorable properties of MPT for their 
growing applications as carriers for sustained drug-delivery and substrates for cell behavior 
control.21 The use of mesoporous titania has been highlighted in previous studies as bone 
anchoring implants to improve apatite formation and subsequent bone bonding22 as well as 
improved osseointegration using local delivery of osteoporosis drugs in vivo.23 Moreover, it has 
been shown that drug loading capacity and release from MPT thin films can be highly 
influenced by altered pore diameter and surface functionalization.24  Considering these 
properties, MPT thin films can be suitable candidates for antibiotic delivery to create 
antibacterial surfaces, and a sustained release of cephalothin and amoxicillin from MPT coated 
implants have previously been reported.25,26 In this thesis, MPT thin films with variable pore 
sizes, synthesized by evaporation-induced self-assembly (EISA) method, have been evaluated 
and assessed as carriers for local-delivery of antibiotics such as Gentamicin, Vancomycin and 
Daptomycin, as shown in Figure 4 (paper I). Additionally, the effect of MPT pore size and 
hydrophobicity without the use of antibiotic on bacterial attachment was investigated.  
 
 
 
 
 
Figure 4. Schematic of antibiotic loading inside mesoporous titania thin films. 
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4.1.3 Polymer PNIPAAm and GNRs 
 
Introducing polymers for local drug-delivery systems is useful for incorporation of large 
amounts of drugs as well as to build up a barrier for prevention of undesired too high burst drug 
release.27 Introducing a polymer layer around a drug carrier, can help controlling and sustaining 
the release of drugs into the surrounding media. Among various types of polymers used for this 
purpose, some polymers show dramatic physical changes upon external stimuli, such as light, 
pH and temperature.28,29 Such properties are attractive for designing controlled drug-delivery 
systems based on polymer response to external factors. For example, the polymer used for 
designing a drug-eluting implant coating, which is introduced in paper II of this thesis, is a 
thermo-responsive polymer, poly(N-isopropylacrylamide) (PNIPAAm). This polymer 
undergoes a phase transition from a swollen hydrophilic state to a shrunken hydrophobic state 
in response to an increase in temperature (Figure 5).30,31  
 
 
A thin layer of PNIPAAm coating onto drug-loaded MPT thin films can function as a pump 
that can affect the drug release using a local heating source to control the release from MPT 
implant coatings. Incorporation of gold nanorods into the polymer, is a suggested strategy to 
absorb light in the near infrared (NIR) and create heat.32–35 With this approach, irradiation with 
NIR can be used as external stimuli to generate heat and create physical change in the polymer 
structure followed by a sustained drug release from MPT thin films (Figure 6). Several studies 
have highlighted the successful performance of gold nanorod incorporated PNIPAAm 
(PNIPAAm-GNRs) upon NIR irradiation.36,37 
 
 
 
 
Figure 5. A schematic of volume phase transition of PNIPAAm from a swollen hydrophilic 
state to a shrunken hydrophobic state below and above the lower critical solution temperature 
(LCST) 
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4.2 Contact killing surfaces 
 
4.2.1 Contact killing 
 
Surfaces can be modified by fixing certain biocides onto them to act on bacterial cells through 
direct physical contact between the substrate and bacterial membrane. Generally, such surfaces 
are created by attachment of biocides onto substrates through chemical immobilization.38 
Active surfaces do not contribute as much to bacterial resistance compared to leaching 
approaches, since they mostly act by causing physical damage to bacterial cells instead of acting 
on a specific target. Such surfaces do not leach biocides into the surrounding and thus do not 
impose negative impact on the local environment.39 Moreover, they usually show broad-
spectrum antibacterial activity and are attractive for prevention of bacterial contamination on 
artificial surfaces. So far, the most studied contact-active biocides are quaternary ammonium 
compounds and N-chloramines.40 Creating a surface with a high positive charge density is the 
main property of such contact killing surfaces that define their antibacterial efficacy.41  
 
 
 
 
 
Figure 6. Schematic illustration of a local drug-delivery system as an implant coating, using 
MPT thin films and PNIPAAm-GNRs. 
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4.2.2 Antimicrobial peptides 
 
In 1939 the very first antimicrobial peptide (AMP) was discovered in an extract from a soil 
bacteria (bacillus) strain and was shown to protect mice from pneumococci infection42 In the 
following years, various types of AMPs have been discovered and found effective against 
several pathogenic bacteria.43 The first animal-derived AMP (Defesnin), isolated from rabbit 
leukocytes, was discovered in 1956 and today, thousands of AMPs have been discovered and 
synthesized.44 Antimicrobial peptides are considered the first defense response towards 
invading pathogens and is present in all classes of life as an important component of the innate 
immune system.42,45 In addition, AMPs have also been found to play an important role in 
regulating inflammatory responses during an infection.46,47  
As the increasing rate of antibiotic resistant microorganisms limits the use of conventional 
antibiotics to treat infections, cationic AMPs have received increased attention as a potential 
alternative.48,49 Such AMPs have generally an amphiphilic structure consisting of <45 amino 
acids. The main mode of AMPs mechanism of action involves direct contact with the bacterial 
surface leading to physical rupturing and breakdown of the cell (Figure 7). The amphiphilic 
structure of AMPs facilitates their binding to both hydrophilic regions (phospholipid head-
groups) and hydrophobic regions (lipid tail-groups) of the bacterial membrane.50 Due to their 
mode of action, AMPs are less likely to induce resistance or tolerance in the cell, compared to 
traditional antibiotics.51 Developing resistance to AMPs would require the bacterium to 
completely change or remodel their membrane structure.42  
 
 
 
 
Figure 7. Simplified schematic of antimicrobial peptide mechanism of action through 
damaging the bacteria cell membrane and succeeding pore formation. 
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One important property of AMPs is their target specificity. Bacterial membranes are mainly 
comprised of anionic phospholipids that carry a net negative charge and are therefore 
susceptible to interaction with the positively charged AMPs.49 The membranes of human cells, 
on the other hand, mainly consist of zwitterionic phospholipids and are enriched in cholesterol 
which results in a less negatively charged membrane and hence less affinity to AMPs.52 
A cationic AMP, RRPRPRPRPWWWW-NH2 was used in this thesis to modify substrates to 
create contact killing surfaces. The peptide consists of a hydrophilic sequence rich in proline 
and arginine amino acids followed by hydrophobic tryptophan residues. The RP side chain 
provides a positive net charge responsible for bonding to negatively charged membranes, while 
the hydrophobic modification by W, has shown to facilitate peptide penetration into the lipid 
membrane.53  
 
 
4.2.3 Covalent immobilization of antimicrobial peptides 
 
Although AMPs have shown unique and attractive properties for use as antibacterial therapeutic 
options, some complexities need to be addressed to bring peptide-based pharmaceuticals into 
clinical use. In release-based approaches, the effective control of the release concentration of 
incorporated peptides is challenging and most of the time after being released into physiological 
environments, they show decreased activity due to rapid protease digestion and peptide 
aggregation and their function is lost within a short time.54,55 Sometimes a high concentration 
of peptides that is used to compensate for their short half-life, can cause cytotoxicity.  Covalent 
immobilization of AMPs onto substrates is a suggested method that has shown to effectively 
enhance their long-term stability and decrease their toxicity towards host cells. Antimicrobial 
properties of AMPs covalently bonded to substrates can be preserved for a longer period and 
those surfaces have shown to have a broad spectrum of antibacterial activity.56–60  
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4.2.4 Elastin-like polypeptides 
 
Elastin in its natural form, is a key extracellular matrix protein that is predominantly found in 
connective tissue and responsible for resilience and elasticity of tissues such as skin, ligaments  
and lungs etc.61 Protein engineering approach has made it possible to design and produce 
elastin-like polypeptides (ELP) with similar properties as natural elastin, as well as to have a 
precise control over the properties of the final protein for use in medical applications.62 
Moreover, protein engineering, makes it possible to incorporate specific individual amino acids 
into the protein sequence for further chemical modifications.63 ELP is synthesized by an initial 
translation of a desired sequence of amino acids encoded into a plasmid using living organisms 
such as bacteria. From Escherichia coli cultures, ELP can be expressed and purified in a large 
scale, Figure 8.   
Cell-adhesive sequences (for example Arg-Gly-Asp, RGD) can be incorporated into ELP initial 
sequence to improve cell attachment properties for applications that demand proper tissue 
integration. It has been shown that ELP surface coatings functionalized with RGD sequences 
favor cell interaction and can promote osseointegration and bone formation.64 ELP is thus 
considered as a promising material for biomedical applications. 
  
 
 
The ELP thin films used for covalent immobilization of AMPs in this thesis, which is discussed 
in paper III, is a block copolymer synthesized recombinantly in Escherichia coli culture. Its 
structure contains four repeats of an elastin-like sequences and an extended fibronectin RGD 
sequence as cell-adhesive domain, as shown in Figure 8. A photo crosslinker is conjugated to 
the incorporated lysine amino acid residues, to provide a photo-crosslinkable ELP for 
fabrication of robust thin films followed by UV-exposure. It has been shown previously that 
ELP thin films can retain their bioactive functionalities after UV crosslinking.63–65  
 
Figure 8. a, Schematic of steps in expression and purification of ELP from E-coli culture. b, 
Proposed ELP structure modified with bioactive RGD sequences. 
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     4.2.5 MF127 hydrogel 
 
Lyotropic liquid crystals (LLC) can be cross-linked and used as soft ordered hydrogels. LLCs 
are formed when amphiphilic molecules, such as a block polymer with alternating hydrophilic-
hydrophobic blocks, through interaction with surrounding solvent molecules self-assemble into 
ordered nanoscale aggregates.66 Depending on factors such as concentration and chemistry of 
the amphiphile, temperature and the type of solvent, LLCs having different geometries ranging 
from example micellar phase (L1), micellar cubic phase (V1), hexagonal (H1) and lamellar phase 
(La), see Figure 9, can be formed.67,68  
Liquid crystalline hydrogels made from polymers exhibit unique properties originating from 
both network structure of the polymer and LLCs. Such hydrogels can swell and hold a large 
amount of water while maintaining their structures and can be considered in the development 
of platforms for variety of biomedical purposes.69  
 
 
 
 
 
 
 
Figure 9.  A schematic phase diagram for an amphiphile in water showing different micellar 
and LLC phases at specific amphiphile structure and temperature. 
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The hydrogels used in this thesis are covalently crosslinked LLCs made of pluronic™ 
diacrylated F127. The hydrogel has a micellar cubic phase, as shown in Figure 10, according 
to F127 phase diagram.70,71 Covalent immobilization of AMPs to such structure, can form a soft 
three-dimensional antibacterial hydrogel with high liquid absorption properties. Moreover, 
these hydrogels have an amphiphilic character along their structure and can expose their 
hydrophilic sites for covalent attachment of AMPs. The hydrophobic parts of the hydrogels also 
provide hydrophobic interaction with amphiphilic AMPs, which is speculated to improve their 
immobilization and stability.  
These hydrogels address the most important criteria of a proper wound dressing as they are 
capable of absorbing and preserving moisture to create a suitable environment in the wound 
and facilitate wound healing and increase comfort.72–74 In addition, such hydrogels are non-
toxic and biocompatible and do not expose any adverse effects on the wound and its 
surrounding.  
 
 
Figure 10. a, Schematic of a micellar cubic LLC phase, the structure of the hydrogel used in this 
work b, Chemical reaction showing the synthesis of the modified Pluronic F127. TEA stands for 
triethylamine. 
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5   Experimental 
 
The experiments performed in this thesis are presented in three sections. The first part is focused 
on use of mesoporous titania thin films as antibiotic carriers for local drug release induced by 
diffusion (paper I), and controlled release using near infrared light (NIR) as an external stimulus 
(paper II). The second part of the experimental is focused on covalent immobilization of 
antimicrobial peptides (AMPs) onto substrates to create contact killing surfaces. The 
experiments were focused on attaching AMPs onto surface coating with RGD motives to create 
a bioactive contact-killing surface as implant coatings (paper III), and onto soft polymeric 
hydrogels to create bactericidal wound patches (paper IV). The third part introduces the 
analytical methods used for evaluation of the formed materials and their properties.  
 
 
5.1 Formation of drug-eluting surface coatings 
 
5.1.1 Mesoporous titania thin film preparation  
 
Cubic mesoporous titania with pore sizes of 4, 6, and 7 nm were formed by the evaporation-
induced self-assembly method (Figure 11). Pluronic® P123 (triblock copolymer EO20PO70EO20) 
and cetyltrimethylammonium bromide (CTAB) (CH3(CH2)15N(CH3)3Br), were used as structure 
directing agents. Larger pores (7 nm) were formed by using an organic additive, polypropylene 
glycol (PPG, Mn ~4,000), which functioned as a swelling agent. A titania precursor solution was 
prepared by adding 2.1 g titanium (IV) ethoxide (20%) to 1.6 g concentrated hydrochloric acid 
(37%) under vigorous stirring, forming a homogenous solution. The amphiphile (0.5 g) was 
separately dissolved in 8.5 g ethanol under vigorous stirring followed by mixing with the 
precursor solution. The final solution was left to stir overnight to achieve a homogenous 
mixture. To obtain uniform thin films of mesoporous titania, 100 μL of the final solution was 
spin-coated (7,000 rpm) for 1 min on glass slides (2×2 cm), titanium discs (8 mm diameter and 
3 mm thickness) and Ti-coated QCM-D sensors using a Spin150 spin-coater. The coated 
substrates underwent aging for 1 day at room temperature to obtain complete self-assembly. 
When the swelling agent was used, a moderately humid environment (RH=54%) was provided 
by a saturated KNO3 aqueous solution in a refrigerator (T=4°C±1°C) during the aging process. 
Finally, the films were calcined by heating with a heating ramp of 1°C/min to 350°C, at which  
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temperature they were left for 4 hours to remove the template and to cross-link the titania. 
Nonporous titania thin films were formed as control samples using the same procedure, but 
without the addition of amphiphiles. To obtain hydrophobically modified MPT thin films, the 
substrates were treated in 5% dichlorodimethylsilane (DCDMS) for 1 hour.  
 
 
 
5.1.2 Antibiotic loading of MPT thin films 
 
Substrate immersion was used to load MPT with antibiotics. The surfaces were immersed in 
antibiotic solutions for 1 hour. Vancomycin and gentamicin were dissolved in water (1 wt%) 
and Daptomycin was dissolved in methanol (1 wt%). DCDMS-treated (hydrophobic) 
mesoporous thin films were used to load Daptomycin, and the non-modified surfaces 
(hydrophilic) were used for Gentamicin and Vancomycin. 
 
5.1.3 Polymer thin film synthesis with incorporated GNRs 
 
To synthesize poly(N-isopropylacrylamide) (PNIPAAm) homopolymers, 1 g NIPAm was first 
purified by recrystallization in hexane prior to use. Then, the NIPAm was mixed with 0.0354 g 
of Azobisisobutyronitrile (AIBN) (mole ratio 1:41 to monomer) and 20 mg of 2-hydroxy-4-
(methacryloyloxy) benzophenone (weight ratio 2% to monomer). The reactants were dissolved 
in 1 ml of ethanol, then kept under gentle stirring for 15 min. Later, the obtained solution was 
transferred to a flask with a septum and purged with nitrogen for 5–10 min to remove oxygen. 
The flask was then immersed in an oil bath at 60 °C and allowed to react for 60 min. The 
reaction was terminated by opening the flask to air, and the flask was stored in the fume hood  
 
 
 
Figure 11. Schematic of the fabrication procedure to form cubic mesoporous titania thin films 
using the evaporation induced self-assembly method. 
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overnight at room temperature. The polymer was obtained in gel form and purified by continued 
washing with milli-Q water to remove unreacted excess reagent. Poly(N-isopropylacrylamide) 
copolymerized with acrylamide (PNIPAAm-AAm) was synthesized by adding 50 and 100 mg  
of acrylamide (5% and 10% weight ratio to NIPAM). The synthesis procedure was the same as 
mentioned above for the pure PNIPAAm. 
 
Gold nanorods with a diameter of 10 nm and a length of 45 nm providing a SPR peak absorption 
of 850 nm were purchased from Nanopartz inc. CO, USA. The GNRs were modified with 
poly(ethylene glycol) (PEG) prior to the experiments to improve their biocompatibility and 
dispersibility.75 In brief, the purchased solution of gold NRs contains the surfactant 
cetyltrimethylammonium bromide (CTAB). Excess CTAB was removed by centrifuging, 
decanting, and resuspending the particles in milli-Q water. Later, 200 μl of 5 mM PEG was 
added to a 1 ml of GNRs solution (2.8 nM), and the mixture was stirred for 24 h at room 
temperature. The resulting mixture was dialyzed the next day to remove any unreacted PEG. 
 
 
5.1.4 Bacteria culture and growth 
 
S. aureus (ATCC 25923) and P. aeruginosa (ATCC 35984) were used to study the bacterial 
attachment and growth on the mesoporous titania with different pore sizes both with and 
without incorporated antibiotics. One day prior to the experiment, a tube of 5 mL tryptic soy 
broth (30 g/L, Sigma) was inoculated by a single isolated colony from cultured agar plates of 
each bacterium. The inoculated cells were cultured in a shaking incubator at 200 rpm for 18 
hours at 37°C until they reached stationary phase. The optical density of the bacterial 
suspension was adjusted to 0.52 at 620 nm (estimated to give 109 colonies) using a plate reader 
(Spectramax M3 Multimode Microplate Reader; Molecular Devices LLC, Sunnyvale, CA, 
USA). 
Each bacterial solution was diluted at a ratio of 1:100 using simulated body fluid supplemented 
with 1% fetal bovine serum (FBS), and the mesoporous titania samples were seeded with 1 mL 
of the diluted solution. The samples with bacteria were then cultured for 1 hour in an incubator 
(ambient air) at 37°C to promote the attachment of the bacteria onto the titania surfaces. After 
1 hour of culturing, media containing the unattached planktonic bacteria was aspirated. The 
samples were rinsed once with PBS and fresh media (simulated body fluid +1% FBS) was 
placed onto each sample. Samples were cultured for another 47 hours and at the end of this time 
period, they were rinsed three times with PBS. Each sample was placed inside a sterile 15 mL 
centrifuge tube filled with 2 mL of PBS. Samples were vortexed at 3,000 rpm for 2 min to 
release adherent bacteria into the PBS solution. Afterward, each bacterial solution was diluted 
twice, 1:10, and then each dilution was plated as five 10 µL spots onto sterile tryptic soy broth 
agar plates. Agar plates were placed inside an incubator at 37°C and 5% CO2 for colonies to  
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grow. The colonies on each plate were counted and the total number of colonies per milliliter 
of vortexed solution was calculated and converted to colony- forming units/ml. 
 
5.1.5 In vitro bacterial growth inhibition test 
 
In paper II of this thesis, Staphylococcus epidermidis (ATCC 35984) was used to assess the 
bacterial growth around PNIPAAm-coated surfaces loaded with Vancomycin. 3 groups of 
substrates including: 1. substrates coated with MPT PNIPAAm loaded with Vancomycin, 2. 
substrates coated with MPT and PNIPAAm with incorporated GNRs and 3. substrates coated 
with MPT and PNIPAAm with incorporated GNRs and loaded with Vancomycin were placed 
in set of Petri dishes inoculated with Staphylococcus epidermidis. For groups 1 and 3, the 
substrates were loaded with Vancomycin by immersing the entire substrate in Vancomycin 
solution (0.2 mg/ml) for 24 h. The next day, the substrates were removed, then dried gently 
with nitrogen gas. Later, the substrates were saved in 12 well plates and kept in the fume hood 
for storage before the bacterial tests.  
 
 
 
 5.2 Covalent immobilization of AMPs onto ELP 
 
5.2.1 Expression and purification of ELP 
 
ELP containing RGD sequences was expressed recombinantly in Escherichia host, as described 
previously.64 A plasmid encoding the elastin-like and RGD sequences was transformed into the 
E-Coli host and isopropyl 𝛽-D-1 thiogalactopyranocide (Sigma) as T7-lac promoter was added 
to induce the expression. After culturing, the bacteria were lysed, and the protein was purified 
using repetitive centrifuge cycles at above and below the lower critical solution temperature of 
the ELP (4°C and 37°C). The purified ELP was dialyzed, freeze dried and stored at 4°C. 
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5.2.2 ELP thin film preparation 
 
A photo-reactive heterobifunctional N-hydroxysuccidimide ester-diazirine crosslinker (NHS-
diazirine, succinimidyl 4,4’-azipentanoate, Pierce Biotechnology) was dissolved in DMSO (2 
mg/mL) and mixed with a solution of ELP in PBS (2 mg/mL). The reaction was incubated for 
2 hours and 1M tris buffer was added to the solution to stop the reaction. The diazirine 
conjugated ELP was dialyzed against DI water, frozen and lyophilized. All ELP coated surfaces 
mentioned subsequently, refers to this photo-crosslinkable form of ELP modified with 
diazirine. Microscope glass coverslips (VWR,15 mm) were cleaned using basic piranha 
solution. The polished titanium discs (grade 4, 8 mm in diameter and 3 mm in thickness) were 
rinsed with 70% ethanol followed by sonication. All substrates were dried with N2 gas and 
stored at 4°C before ELP deposition. A 50 mg/mL (5 wt. %) solution of ELP in PBS was 
prepared at 4°C. The deposition of ELP onto the substrates was performed by spin-coating. For 
the glass substrates, 50 l of the ELP solution and for the Ti discs 30 mL of the ELP solution 
was applied to the center of the surface and spun at 4000 rpm for 90 seconds. The spin coated 
substrates were treated by UV-light using a 365 nm, 8 W light source for 1 hour for ELP 
crosslinking. The crosslinked films were rinsed 3 times for 0.5 hour with PBS prior to the 
experiments to remove any non-crosslinked ELP.  
 
5.2.3 Formation and modification of hydrogels (MF127) 
 
A mixture of Pluronic F127 (30 wt%) and water (70%) was made to form a micellar cubic liquid 
crystalline phase according to the phase diagram71. Irgacure 2959 was added to the mixture of 
Pluronic F127 (2 wt%) as a photoinitiator. Mixing was performed in 20 ml glass vials manually 
using a spatula until a thick and homogenous gel formed. The gels were spread onto glass slides 
and kept in a sealed container overnight to set into ordered phase. The gels were then UV 
polymerized using a UV LED curing system (90 W, 𝜆= 365 nm) for 10 min to form a flexible 
polymeric hydrogel with a thickness of 4-5 mm. The gels were cut into desired shapes and 
washed in milli-Q water for 48 h to remove the unwanted by-products and get into their fully 
swollen shape before further analysis and AMP attachment. 
Pluronic F127 (EO100PO70EO100) was chemically functionalized with polymerizable diacrylate 
head groups as previously reported.70,76 The modified polymer was used for manufacturing of 
crosslinked F127 hydrogels for AMP modification. Briefly, acryloyl chloride was dissolved in 
chloroform (0.012 mol) and added dropwise to a mixture of Pluronic F127 (EO100PO70EO100) 
(0.003 mol) and triethylamine (TEA) (0.006 mol) in CHCl3 under N2 atmosphere and magnetic 
stirring for 24h at RT. The mixture was then washed with the same volume of Na2CO3 solution 
(aq, 5wt %) for three times and dried over anhydrous MgSO4 and the solvent was evaporated 
under reduced pressure to result in a white powder as final product (80% yield). 
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5.2.4 AMP immobilization onto ELP surfaces and hydrogels 
 
A solution of antimicrobial peptide RRPRPRPRPWWWW-NH2 (RRP9W4N, Red Glead 
Discovery AB, Lund, Sweden) was prepared in sterilized water to a concentration of 200 μM.  
For covalent attachment of AMP to the ELP surfaces, the ELP coated substrates were 
submerged into a solution of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC) and N-Hydroxysuccinimide (NHS) in MES buffer (pH=6) at a final concentration of 2 
mg/mL and were allowed to react for 30 min slowly shaken at room temperature. 
 
5.2.5 Bacteria culture 
 
S. epidermidis (ATCC 35984), S.  aureus (CCUG 56489) and P. aeruginosa (CCUG 10778) 
were used to assess biofilm formation on the surfaces. A sterilized 10 µL loop was used to 
withdraw a single colony from cultured agar plates of each bacterium to inoculate a tube of 5 
mL tryptic soy broth (TSB) one day prior to experiment. The inoculated cells were cultured in 
the incubator for 6 h, diluted in TSB and cultured in the incubator overnight to reach the 
stationary phase for bacterial growth.  
The optical density of the bacteria culture was adjusted to 0.7 at 620 nm (estimated to give 109 
colonies) using a spectrometer. The bacterial suspension was centrifuged for 10 min at 2500 
rpm and the formed bacteria pellet was suspended in the fresh TSB media. 2 mL of the 
suspension was seeded onto the glass substrates, ELP coated substrates, activated ELP 
substrates and AMP functionalized ELP substrates in a 12 well plate. Bacteria were then 
cultured for 24 hours and 48 hours under standard culture condition (ambient air at 37°C) to 
promote biofilm formation onto the surfaces. For 48 hours’ time point, after 24 hours of culture, 
the media was aspirated and replaced with fresh TSB for another 24 hours culture. At the end 
of each time point, surfaces were rinsed 3 times with fresh PBS to wash off any unattached 
planktonic bacteria before biofilm analysis. The same bacteria culture method has been used 
for materials involved in paper II, III and IV. 
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5.2.6 MRSA and MDR E. Coli culture  
 
A single bacterial colony of MRSA (ATCC® 43300™) and MDR E. Coli (ATCC® BAA-
2471™), isolated from cultured agar plates, were inoculated in a tube of 5 ml tryptic soy broth 
(TSB) and cultured in a shaking incubator at 37° overnight. The OD of the bacterial suspension 
was adjusted to 0.52 at 620 nm (estimated to give 109 colonies). To achieve a concentration of 
106 CFU/ml the suspension was diluted 1000x further using TSB. Samples were placed in a 
standard 24 well plate and 1 ml of the bacterial suspension was used to seed each sample 
followed by incubation for 24 h under standard culture condition (5% CO2, 95% air at 37 °C). 
 
5.2.7 Evaluation of stability in serum 
 
Fluorescent tagged AMP (5(6) carboxyfluorescein-RRPRPRPRPWWWW-NH2) was used to 
study the stability of AMP attachment and its distribution on ELP surfaces after various duration 
of time. The tests were performed by incubating the fluorescent AMP functionalized surfaces 
in 20% human plasma serum (from 1 hour up to 3 weeks) and imaged using fluorescent 
microscopy.  
 
Stability of AMP-hydrogels was tested upon incubation in human serum followed by bacterial 
assays using S. aureus. The tests were run in duplicate for 9 different time points. At each 
desired time point, the serum was removed, the gels were washed in PBS and bacterial assays 
were performed. 
 
5.2.8 Zone inhibition 
 
In order to show that the AMPs are covalently bonded onto hydrogels and they are not leaking 
into the bacterial culture, a zone inhibition test was performed. The bacteria culture was made 
in TSB at an optical density (OD) between 0.55 and 0.7. The bacteria pellet was collected by 
centrifuging at 2500 rpm and suspended in fresh 20 ml TSB (109 CFU). BHI agar plates were 
streaked with 100 µL of the bacterial suspension. The gels (2 of each hydrogel with and without 
AMP) was placed on top of the agar plates. As a second control, hydrogels submerged in same 
solution of AMP (200 µM) was prepared to show the leakage difference between covalent and 
physical attachment. The plates were incubated at 37°C overnight. Afterwards the zones around 
the gels where no bacteria were grown, were measured and compared between the samples. 
This inhibition zone area was considered as leakage of AMP from the hydrogels.   
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5.2.9 Bacterial live/dead analysis 
 
Fluorescent microscopy with live/dead staining was performed to analyse the live and dead 
population of bacteria in contact with surfaces. The bacterial solution was removed from the 
hydrogels incubated in bacterial culture and the samples were gently rinsed twice with PBS. A 
drop of live/dead staining solution, LIVE/DEAD® BacLight™ Bacterial Viability Kit L7007, 
was placed on the top of the sample to cover its surface. The samples were incubated for 10 
min at RT in a dark environment before the biofilm analysis. 
 
5.2.10 Cell culture and growth 
 
5.2.10.1 hMSC cell culture 
 
Human bone marrow-derived mesenchymal stem cells (ATCC®_ PCS-500-012TM) were sub-
cultured according to supplier’s instruction. Briefly, Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen, USA) containg GlutaMAX, 4.5 g/L glucose, 110 mg/ml sodium pyruvate, 
10% fetal brovine serum and 1% penicillin/streptomycin was used to culture and expand cells 
at 37°C and 5% atmospheric CO2. The following osteogenic supplements were also included 
in cell studies: 100 mM dexamethasone, 50 µg/ml ascorbic acid, and 10 mM β-
glycerophosphate. Cells were pre-washed in DPBS before passaging by 0.05% trypsin-EDTA. 
Cells were seeded onto 12-mm Ti disks and placed in 24 well plates at a density of 10,000 
cells/discs. 
 
5.2.10.2 Mineralization assay 
 
Calcium phosphate mineralization is an early-stage phenotypic marker of new bone formation. 
To run the mineralization assay, samples were seeded as previously described and rinsed in 
PBS (pH 7.4) and moved to new well plates. 1 ml of HCl (0.5 M) was added to each sample 
and left overnight on a rocker. Using Calcium o-Cresolphthalein Complexone (CPC) Liquicolor 
Test (Stanbio Laboratory, USA), the content of calcium was measured. Quantification of 
calcium content was done by correlating the calcium standard curve, obtained by absorption 
measurements at 550 nm, and dividing by substrate area to convert to calcium surface density. 
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5.2.10.3 Alkaline phosphate assay 
 
Alkaline phosphatase (ALP) activity is one of the most widely employed markers for mid-stage 
osteogenic differentiation.77 Since ALP is cellular ALP, its activity was quantified using the 
SIGMAFAST p-nitrophenyl phosphate tablet kit (p-NPP kit, Sigma Aldrich Co. St Louis, MO, 
USA), and normalized to total DNA content using the PicoGreen assay kit (Quant-iT 
PicoGreen, Molecular Probes). Samples were seeded with cells as previously described above, 
rinsed with PBS and moved to 24 well plates. A buffer containing 10 mM Tris (pH 8), 1 mM 
MgCl2, 20 µM ZnCl2 and 0.02 % Triton X-100 in deionized H2O was added to the cell to lyse 
them. Samples were frozen at -80°C, thawed and assay was conducted. Double stranded DNA 
content was quantified by measuring sample fluorescence and according to instructions 
provided for the PicoGreen assay kit and compared to a known DNA standard curve. Same 
lysate was used to assay ALP activity. Lysate was mixed with a p-NPP solution (5 mM), while 
an ALP solution was mixed with serial dilutions of this p-NPP solution. Samples were 
incubated for 1h in room temperature in the absence of light. NaOH (3 M) was added to each 
well to stop the incubation and the absorbance at 405 nm was measured and correlated with the 
standard curve. The reported ALP activity has been normalized to total DNA content for each 
sample. 
 
 
 5.2.10.4 MTT assays  
 
Primary fibroblasts (Gibco™ Human Dermal Fibroblasts, adult (HDFa)), were received from 
Fisher scientific, thawed and sub-cultured according to the supplier’s recommendation. Briefly, 
cells were cultured and expanded in cell media with 1 Gibco™ Low Serum Growth Supplement 
Kit containing gentamycin/amphotericin solution with 10 % FBS at 37 °C and 5 % atmospheric 
CO2. To perform MTT assays, hydrogel samples (thin hydrogel discs punched out with a 4 mm 
biopsy punch) were soaked in 1 ml DMEM for 3 days. 200 µl of the sample exposed media was 
added to the wells of a 96 well plate. As positive controls, media not exposed to any samples 
were used. The cell density of the fibroblasts was calculated with the help of a Bürker counting 
chamber. 5,000 cells were then added to each well. The well plate was incubated at 37 °C for 3 
days. After 3 days of incubation, the media was aspirated from each well and replaced with 100 
µl of fresh media (of corresponding type) to which 10 µl of the MTT solution (5 g MTT in 1 
ml of PBS) was added and mixed gently by pipetting. The plate was put back into the incubator 
for 4h. 100 µl of the SDS solution (1 g of SDS in 10 ml of 0.01 M HCl) was added to each well 
and placed in the incubator for another 4 hours. The absorbance of each well was read at 570 
nm by a spectrometer (Thermo scientific Multiskan GO). The negative control (media put 
through the MTT staining without any cells in it) absorbance was subtracted from each value 
and the viability of the cells were calculated by dividing of absorbance values by the mean of 
the positive controls. A value of 75% was considered as standard non-toxic sample. 
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5.2.11 Blood coagulation test (platelet count) 
 
Prior to the experiment, blood collecting Eppendorf tubes, pipette tips and tubings to draw the 
blood, were heparinized to avoid unwanted blood activation. Heparinization was done by a 
layer-by-layer assembly method with alternating incubation with a polymeric amine and a 
heparin conjugate to obtain a double-coated heparin layer according to the Corline method 
(Corline Biomedical AB, Uppsala, Sweden). 
Fresh blood from 2 healthy volunteers were collected in heparinized tubes containing 1 IU/ml 
of heparin solution (Leo Pharma A/S, Ballerup, Denmark). The blood was used fresh after 
sampling. 1 ml of blood was collected in an Eppendorf tube with 4 mM EDTA to be used as a 
reference point (named initial). Samples were conditioned by adding 1 ml of PBS and were 
shaken at 600 rpm for 30 min prior to the experiment. The hydrogels (control and AMP 
modified) were placed in heparinized 2.5 ml Eppendorf test tubes. 100 µL of PBS was added 
in order to soak the samples. Then 1 ml of fresh blood was added to each tube. The tubes were 
then rotated on an orbital shaker (incubating Waver, VWR) for 60 min at 37°C. As blank 
controls, 1 ml of blood was added to an Eppendorf tube without any hydrogels and treated with 
the same conditions. After the experiments, the blood was carefully collected from the tubes 
and mixed with EDTA giving a final concentration of 4 mM. The number of platelets were 
counted using a sysmex XP-300 hematology analyzer (Kobe Japan) directly after the 
experiment. Samples were run in duplicate with blood from each donor. Ethical approval was 
obtained from the regional ethics committee (Dnr:2008/264). 
 
5.2.12 Pilot in vivo test 
 
5.2.12.1 Animal handling  
 
Seven female Sprague–Dawley rats (200–300 g) fed on a standard pellet diet and water were 
used in the study, which was approved by the Local Ethical Committee for Laboratory Animals 
(Dnr 1091/17). The animals were housed together (2–3 rats/cage) and were kept in an infection 
unit at the animal facility with daily supervision. Anasthesia was induced by isoflurane 
inhalation (4% with air flow of 650 ml/min) and maintained with continuous administration of 
isoflurane (~2% with an air flow of 450 mL/min) via a mask (Univentor 400 anaesthesia unit, 
Univentor, Zejtun, Malta). The back of the rats was shaved and cleaned with chlorhexidine (5 
mg/mL; Fresenius Kabi, Norway). Six separate incisions were made on the back and pockets, 
into which hydrogel disks were inserted, were created by blunt dissection in the soft tissue under 
the skin. 
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5.2.12.2 Surgical Procedure 
 
On the back of each rat, three control hydrogels and three AMP-hydrogels were inserted. The 
control hydrogels were inoculated by 50 μL of saline with and without Staphylococcus aureus 
(ATCC 25923) in two different dosage of 104 and 2x106 CFU. The wounds were then carefully 
closed with intracutaneous sutures, followed by two to three simple sutures (Ethilon 5-0 FS-2, 
Eticon™, Johnson & Johnson, Scotland). The back was cleaned with saline and each rat 
received analgesics at a dose of 0.03 mg/kg (Temgesic®, Reckitt Benckiser, UK). 
After 24 h and 72 h, the animals were sacrificed with an overdose of pentobarbital (60 g/L, 
APL, Sweden) after a short anesthetic induction with isoflurane. The back of the rats was 
cleaned with chlorhexidine and all the sutures were removed. The implants were retrieved, and 
the exudates were obtained from the pockets by repeated aspiration (5x) with 500 mL phosphate 
buffered saline (PBS) and kept on ice to study CFU and bacterial viability.  
 
5.3 Analytical methods 
 
5.3.1 Material and surface evaluation 
 
5.3.1.1 SEM and TEM 
 
In scanning electron microscopy (SEM), a beam of focused electrons is scanned over a solid 
sample to give highly resolved images. The highest resolved images are obtained by detecting 
the signal from the secondary electrons that originate from the surface. In transmission electron 
microscopy (TEM), an accelerated high energy beam of electrons passes through ultra-thin 
samples and creates a high-resolution image revealing the microstructural information. In paper 
I and II, SEM and TEM were extensively used for imaging the mesoporous titania thin films 
and powders. In paper II, SEM was used to evaluate the mesoporous titania and the polymer 
coating. In paper III, SEM was used to image ELP thin films and morphology of the bacteria in 
biofilms formed on surfaces. All samples in the second part were gold sputtered at a rate of 3 
nm/min for 1 min prior to SEM imaging.   
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5.3.1.2. Small angle X-ray scattering 
 
Long-range structural order within materials can be revealed by means of small-angle X-ray 
scattering (SAXS). The scattered X-ray patterns reveal information about long-range 
periodicity and mesoscopic dimensions of the samples. In paper I, mesoporous titania was 
grinded into a powder for SAXS measurements. The measurements were performed at MAX-
lab, beam station I911 (Lund, Sweden) using synchrotron radiation (𝜆= 0.91 Å) and a two-
dimensional Mar 165 CCD detector. 
 
5.3.1.3. X-ray diffraction 
 
X-ray diffraction is a method to determine the crystalline structure of a sample. When the 
sample is exposed to an X-ray beam, the atomic planes in the crystallites diffract the beam at 
certain angles with constructive interference of X-ray to fulfil the Bragg condition (Equation 1) 
(Eq. 1)                          n𝜆 = 2dsin𝜃 
Where d is the lattice spacing, 𝜃 is the angle, n is an integer value and 𝜆 is the wavelength of 
the incident beam. In paper I, the crystallinity of the mesoporous titania powders were evaluated 
by XRD. The X-ray diffractometer used was a Bruker D8 advance (Bruker Corporation, 
Billerica, MA, USA) with a radiation wavelength of 1.5405 Å (Cu Kα1 radiation). 
 
5.3.1.4 Differential scanning calorimetry (DSC) 
 
Determining the phase transition temperature (Tph) to identify the volume-phase transition 
behavior of PNIPAAm and PNIPAAm-AAm polymers was done in paper II. The Tph was 
defined by the point between the moment of increase in the DSC endotherm and the maximum 
of the DSC peak. For this purpose, a scanning calorimeter was used (Perkin – Elmer 
Instruments, USA). In this test, 5 mg of polymer was immersed in milli-Q water for 1 day to 
reach the equilibrium state. Later, the samples were sealed in aluminum pans and scanned from 
22°C to 45°C under a dry nitrogen atmosphere at a heating rate of 1°C/min. 
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5.3.1.5 X-ray photoelectron spectroscopy 
 
X-ray photoelectron spectroscopy (XPS) also known as electron spectroscopy for chemical 
analysis (ESCA) is a surface sensitive analysis technique to determine the chemical 
composition of a surface. Low energy X-rays irradiate the sample and the binding energy and 
intensity of the photoelectrons leaving the sample allow for identification and quantitative 
determination of the elements present at the surface of the sample. In part 1 of the thesis, XPS 
was used to examine the surface composition of mesoporous titania thin films before and after 
modification and drug loading. In part 2, XPS was used to evaluate the ELP thin films before 
and after surface activation with EDC and NHS. The equipment used was a Quantum 2000 
scanning microscope (Physical Electronics, Inc., Chanhassen, MN, USA) with a 100 µm point 
diameter at a 5 nm analysis depth. 
 
5.3.1.6. Atomic force microscopy 
 
Atomic force microscopy (AFM) is a scanning probe microscopy method to measure local 
properties of a surface such as its roughness through interactive forces. In paper I, AFM was 
used to measure the surface topography of the mesoporous titania films. The measurements 
were performed in semi-contact or intermittent mode at two different scan sizes (1 and 0.5 µm). 
A conical tip with a length of 200 nm and a radius of 5 nm attached to an NT-RTESPA 
cantilever was used to scan the samples. The AFM used was an NT-MDT model (Moscow, 
Russia). 
 
5.3.2 Antibiotic release, AMP attachment and stability evaluations  
 
5.3.2.1 QCM-D 
 
Quartz crystal microbalance with dissipation monitoring (QCM-D) is a mass sensitive 
analytical technique. Upon application of an AC voltage, a thin quartz crystal attached to a pair 
of gold electrodes, starts to oscillate at its acoustic resonance frequency. The mass uptake or 
release at the sensor surface causes changes in the resonance frequency (Δf) as a function of 
time. Δf can be converted to rigid mass adsorbed or desorbed (Δm) by applying the Sauerbrey 
equation (Eq. 2). 
 
(𝐸𝑞. 2)                                       ∆𝑚 = −
∆𝑓 × 𝐶
𝑛
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, where C = 17.7 ng Hz-1 cm-2 for a 5 MHz crystal and n is the overtone resonance number. 
Moreover, an energy dependent property of the surface, the dissipation (D) can be measured by 
QCM-D. ΔD is correlated to the changes in viscoelastic properties of the adsorbed layer. 
In paper I and II, QCM-D was used to measure the absorbed mass of the drugs within the 
mesoporous titania thin films. In addition, the accessible pore volume was calculated from the 
amount of deuterium oxide (D2O) that was absorbed. In part 3, the adsorption and release 
behavior of antimicrobial peptides onto ELP surfaces before and after EDC/NHS activation 
were monitored by QCM-D and compared to pure Ti surfaces. The swelling ability of the ELP 
thin films was also measured by D2O absorption tests. The instrument used was a Q-sense E4 
and all samples were evaluated using titanium QCM-D discs (QSX 310, Q-sense). 
 
5.3.2.2 Ultraviolet-Visible (UV-VIS) spectroscopy 
 
Ultra-violet and visible radiation interact with matter which causes electronic transitions. This 
method is routinely used in analytical chemistry for quantitative determination of ions, 
compounds and macromolecules in solution. In paper II, phenol was selected as the drug model 
to evaluate the drug release from PNIPAAm-coatings in response to NIR irradiation by the use 
of UV/VIS spectroscopy (Agilent 8453, USA). PNIPAAm-coated glass slides (with or without 
GNRs). The coated and drug-loaded surfaces were placed in the bottom of UV-VIS cuvettes 
followed by adding 2 ml of milli-Q water. One cuvette was filled only with milli-Q water and 
used as a blank. The phenol absorbance was measured at a wavelength of 269 nm. Then, the 
samples were subjected to NIR light for 30 min. The absorbance was registered for each sample 
(n=4) at each data point. The standard calibration curve of the absorbance as a function of the 
phenol concentration was obtained at 269 nm (Appendix A). Results are presented as the mean 
value. 
 
 
5.3.3 Bacterial attachment and viability evaluation 
 
5.3.3.1 Fluorescence light microscopy  
 
Fluorescence light microcopy (FLM), is used to image samples that are either fluorescently 
labeled or fluorescing in their natural form (autofluorescence). When fluorescent samples are 
irradiated with absorbable light of a specific wavelength, they can emit energy detectable as 
visible light. In this technique, the microscope filters out only the desired wavelength that 
matches the fluorescing sample. As a result, the electrons in the fluorescing specimen are 
excited to a higher energy level and when they relax, emit visible light. The emitted light 
reaches a second barrier filter to eliminate the residual background light from the specimen to 
pass to the eye or camera. Thus, the fluorescing sample shine out against a dark background  
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with high contrast. FLM was extensively used in this thesis to study the live and dead fractions 
of biofilms formed on substrates. The microscope used was a Carl Zeiss GmbH (Jena- 
Germany) equipped with an HBO 100 microscope illuminating system. Green filter, GFP, 
38HE (λExcitation = 470 nm and λEmission = 525 nm) and red filter ( λExcitation = 545 nm and λEmission 
= 605 nm) were used for imaging. The biofilms were stained using LIVE/DEAD® BacLightTM 
Bacterial Viability kit (Molecular Probes, Invitrogen). The images were obtained with SYTO® 
9 and propidium iodide nucleic acid staining provided in the kit. Live bacteria with intact cell 
membranes appeared green and dead bacteria with compromised membranes appeared red. The 
statistical data from live/dead bacteria obtained from red and green fractions of fluorescent 
microscopy images were presented by the mean value with standard deviation (paper I and II).  
All the experiments were performed three times with two replicates. 20 images from each 
surface were used to obtain the image analysis data.  FML was also used to image fluorescent 
tagged antimicrobial peptides to study their stability in serum condition (paper III).  
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6 Results and discussion 
 
The results that are presented and discussed in this thesis are divided into two parts. The focus 
of the first part is on the evaluation of the antibacterial performance of mesoporous titania thin 
films and their function as antibiotic delivery systems in two drug release approaches: a 
diffusion-based drug release from mesoporous titania thin films with variable pore sizes and 
hydrophobicity (paper I), and a photon-induced controlled release system from mesoporous 
titania films embedded in polymer PNIPAAm with incorporated gold nanorods (paper II).   
In the second part, the antibacterial performance and evaluation of contact-killing surfaces are 
in focus. Such materials are designed by covalent immobilization of cationic AMPs onto 
suitable substrates including elastin-like polypeptides with cell-adhesive RGD motives to create 
bioactive antibacterial implant coatings (paper I) or onto an ordered soft polymeric hydrogel to 
be utilized as absorptive antibacterial wound patches (paper II). 
 
 
6.1 Antibacterial properties and drug-release from 
mesoporous titania thin films  
 
6.1.1 Evaluation of mesoporous titania thin films 
 
The morphology of formed mesoporous titania thin film (MPT) on titanium substrates was 
visualized by SEM. SEM micrographs presented in Figure 12 show an evenly distributed porous 
structure with pore accessible from the surface. Moreover, SEM was used to image MPTs in 
combination with thin polymer layer on top with incorporated gold nanorods (GNRs). The SEM 
images showed a well-defined porous structure with a pore size of 6 nm covering the whole 
titanium surface protected by a 200 nm polymer film with incorporated GNRs (Figure 13a). A 
homogenous distribution of GNRs was observed which is crucial to preserve the absorption of 
NIR light in the polymer film. The film thickness was measured by cross-section analysis, 
which was ~200 nm for the ones formed using pluronic P123 and CTAB and ~700 nm when 
the swelling agent PPG was added to P123, Figure 12b. The increase in the film thickness can 
be explained by the increased viscosity of the coating solution by adding PPG, resulting in a 
thicker film upon spin coating. The thickness of the MPT- PNIPAAm was a total of 500 nm, 
which consisted of 300 nm MPT and 200 nm PNIPAAm layer (Figure 13). 
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The average pore sizes of MPTs formed with different templates were calculated using image 
analysis of SEM and TEM micrographs and are shown in Table 1. The pore volumes of the 
films were calculated by the QCM-D data obtained from H2O/D2O exchange experiments using 
the mass difference between water and heavy water. As expected, the volume increased with 
increasing pore size and increased film thickness and the size/volume of the formed pores 
correlates well with the size/volume of the templates used in the synthesis. The overall results 
from evaluation of MPT suggest a versatile structure with tunable pore sizes and pore volumes 
that enable loading of drugs having different size.  
 
 
Figure 12. a, SEM Micrographs of mesoporous titania thin films formed using different 
templates; from left to right CTAB, P123 and P123+PPG (1:1). b, SEM images of the cross-
section of mesoporous titania coatings, CTAB, P123 and P123+PPG (1:1) from top to bottom. 
c, TEM images of mesoporous titania thin films scraped off from the substrates CTAB, P123 
and P123+PPG (1:1) from left to right. d, A graph showing the pore sizes obtained from the 
TEM micrographs.  
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Table 1. Properties of mesoporous titania thin films including average pore diameter obtained 
from SEM images, the percentage of pore coverage on the surface calculated from SEM images 
and the pore volume of the mesoporous titania thin films accessible for water obtained from 
QCM-D measurements.  
 
Template Average 
pore 
diameter 
(nm) 
Pore 
surface 
coverage 
(±5%) 
Pore 
volume 
(%) 
 
CTAB 4 18 75 
P123 6 25 57 
P123 + 
PPG (1:1) 7 42 55 
 
 
 
 
Figure 13. SEM image showing: a, Top view of the mesoporous titania (MPT) film. b, A cross 
section of mesoporous titania film, where the black line indicates the film thickness. c, Top 
view of the GNRs on the PNIPAam. The inset shows the rods at higher magnification and d, A 
cross section view of the MPT film and PNIPAAm layer. 
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When analyzed with SAXS, clear Bragg peaks with different intensities and at different 
positions were apparent in diffractograms for the mesoporous samples, while no peaks for 
nonporous sample were observed, Figure 14b.  Relatively broad peaks indicate that the degree 
of order was relatively low, which is probably a result of the spin-coating technique used. It has 
been discussed before that thin films formed by dip coating instead of spin coating usually show 
higher degree of order while the films formed by spin coating are more homogenous in 
thickness.78  
XRD results showed the formation of crystalline anatase TiO2. The crystalline structure did not 
change by changing the pore sizes and was the same for all the samples including the nonporous. 
In Figure 14a, a representative diffractogram for the titania films is shown. 
 
Figure 14. a, A representative XRD pattern obtained from mesoporous titania powders. b, 
SAXS diffractograms of mesoporous titania powders, see the graph legend for the sample 
names.  
From the combined material characterization results it was clearly seen that the physical and 
chemical properties of the mesoporous titania thin films remained the same independently of 
pore size, a prerequisite for investigating the effect of pore size alone on drug loading and 
antibacterial responses.  
 
6.1.2 Titania thin films and antibiotic delivery 
 
When MPT thin films were loaded with antibiotics and the release was driven by diffusion upon 
rinsing with solvents, a high loading efficiency and fast release rates were observed according 
to QCM-D measurements, as is shown in Figure 15. The amount of drug loading correlated 
well with the pore size and accessible volume of the pores as measured by H2O/D2O absorption.  
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Since the release of the drugs from MPT thin films are mainly driven by diffusion from the 
pores upon rinsing with solvent, the burst release could not be controlled. The rinsing rate 
during the QCM-D measurement was set to 50 mL/min. This rate is considered to give rise to 
a much higher release compared to physiological conditions. Therefore, the results from the 
release kinetics cannot be directly transferred to the clinical situation. However, as discussed 
above a high initial release from antimicrobial coatings can also be useful to clear the 
environment around the implant from bacteria and prevent bacterial colonization in adjacent 
tissue.4  
The dissipation did not change noticeably during loading of the drugs, indicating that no 
viscoelastic film was formed onto the mesoporous titania and that the adsorption of drugs is 
limited only to the pores. 
 
Figure 15. QCM-D recordings obtained from loading and release of the three different 
antibiotics: a, Gentamicin, b, Vancomycin, and c, Daptomycin from mesoporous titania with 
variable pore sizes (For Daptomycin DCDMS modified surfaces were used).  
* Indicates start of rinsing with solvent to follow the release. 
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To control the burst effect and to be able to design a system that enables a controlled drug 
release, mesoporous titania thin films with pore size of 6 nm were coated with a layer of 
thermoresponsive PNIPM polymer with incorporated gold nanorods. Such system utilizes gold 
nanorods to generate heat upon absorption of light in the near infrared (NIR) spectrum. This 
amount of heat induces shrinkage of the PNIPAAm and thus release of the drug molecules. The 
use of NIR light as an indirect stimulus for drug release is claimed to be harmless to the body 
tissue, since light with such wavelengths can penetrate deeply without being absorbed by cells 
and hemoglobin.79  
The results from differential scanning calorimetry (DSC) analysis showed that PNIPAAm 
containing 10% acrylamide had a phase inversion temperature of 42°C, Figure 16. This 
temperature is considered suitable for intended in vivo application and can be achieved by the 
heat generated from GNRs upon NIR radiation.  
 
 
 
Figure 16. DSC scans of PNIPAAm and PNIPAAm-AAm polymers (at a heating rate of 1°C 
/min).  All data is presented as a mean value (n=3).  
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Phenol was selected as a model drug to evaluate the drug-release of MPT- PNIPAAm-coated 
surfaces upon irritation with NIR by UV/VIS spectroscopy. No pre-leakage of phenol before 
irradiation was observed. Upon irradiation, the MPT- PNIPAAm surfaces that contained gold 
nanorods showed an immediate release of phenol. Such behavior is probably due to a sudden 
physical contraction of the thermoresponsive polymer as response to the heat generated by 
GNRs upon irradiation. Intriguingly, even after termination of irradiation, the release of phenol 
was continued, Figure 17. This indicates that the drug release from such system cannot be 
totally halted, but only initiated using NIR.  However, the data from QCM-D measurements 
indicated that the polymer films can re-swell to their initial state before NIR irradiation. Thus, 
the continued release indicates some permanent change in the structure of the polymer induced 
by NIR. Thus, we could not claim a cycle of phenol release and uptake induced by NIR. In 
addition, the polymers with no GNRs, revealed a slight release of phenol upon irradiation both 
in UV/VIS and QCM-D measurements, suggesting some absorption of NIR by the polymer 
itself.  
 
Figure 17. Changes in the phenol concentration upon irradiating the coated surfaces with NIR. 
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6.1.3 Bacterial assays for drug-delivery evaluation 
 
The results from bacterial assays showed that mesoporous titania thin films can to some extent 
hinder bacterial growth without the presence of any antibiotic. The bacterial assays showed that 
the presence of pores alone can affect the growth of bacteria S. aureus and P. aeruginosa onto 
surfaces, Figure 18a. Further assessments are required to conclude if the decrease in bacterial 
adhesion is merely due to the change in surface energy and nanotopography of the substrates 
or the fact that changing these parameters can affect the absorption of serum proteins present 
in the media and therefore the subsequent bacterial adhesion. The lowest number of bacteria 
was found on hydrophobically modified MPT with a pore size of 4 nm. The results indicate that 
the bacterial attachment was generally lower when the surface energy was decreased.  
When the MPT surfaces were loaded with different antibiotics, a more predictable pattern of 
decreasing bacterial attachment with increasing pore size was observed. According to our 
QCM-D results shown in Figure 15, more antibiotics was loaded into and released from MPT 
with bigger pore sizes. These results confirm that MPT films can potentially be used as tunable 
drug release coatings on implants to decrease the initial attachment of bacteria and subsequent 
biofilm formation. However, such release behavior is not controlled and sustained over a longer 
time period.  
 
To further investigate the effect of the photoinitiated MPT-PNIPAAm system, Staphylococcus 
epidermidis (ATCC 35984) was used to assess the bacterial growth around the PNIPAAm-
coated surfaces when loaded with the antibiotic Vancomycin. The results from a zone inhibition 
study, shows a clear inhibition zone around the radiated MPT-PNIPAAm with incorporated 
GNRs, while such zone was absent for all the other test groups upon irradiation (Figure 19). 
The inhibition zone indicates the release of Vancomycin from the MPT-PNIPAAm system and 
extended a couple of millimeters all around the sample. Since no inhibition zone was detected 
before irradiation, it can be concluded that polymer layer preserved the drug loading inside 
MPT and irradiation with NIR succeeded in initiating the drug release.  
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Figure 18. Data from counting the colony forming units grown on modified and unmodified 
mesoporous titania a, without the presence of antibiotics. b, with and without Gentamicin c, 
with and without Vancomycin d, with and without Daptomycin. Values are mean ±SD, N=3, 
*p<0.05 compared to mesoporous titania surfaces for each bacteria strain. MPT = mesoporous 
titania. 
 
 
Figure 19. Representative images show zone of inhibition results for Staphylococcus 
epidermidis around the samples due to irradiation with NIR. PNIPAAm samples loaded with 
antibiotic, a, before and b, after irradiation, PNIPAAm samples incorporated with GNRs, c, 
before and d, after irradiation, and PNIPAAm samples incorporated with GNRs and loaded 
with antibiotic, e, before and f, after irradiation. 
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6.2 Antibacterial performance and evaluation of contact-
killing surfaces 
 
6.2.1 Material evaluation and AMP attachment 
 
An alternative to drug-eluting surface coatings to combat bacterial colonization and subsequent 
infection on biomedical devices is to design contact killing surfaces. Such surfaces do not 
release any antibacterial drugs but rapidly kill bacteria upon contact. The contact killing 
surfaces in this thesis are based on covalent immobilization of AMPs onto different substrates 
using NHS-EDC coupling chemistry. Immobilization of antimicrobial peptides onto surfaces is  
suggested to be an effective approach to minimize their cytotoxicity and increase their long-
term stability, which is needed for clinical applications.80–83 In this thesis, EDC was used to 
activate carboxyl groups on the substrates to react with primary amine groups present in the 
AMP structure. The use of NHS improves the bonding efficiency and increases the dry-state 
stability after immobilization.84 Two substrates for covalent immobilization of AMPs were 
chosen; photo-crosslinked ELP thin films with cell adhesive RGD sequences, and ordered 
nanostructured hydrogels made of cross-linked pluronic™ F127 block copolymers. The former 
substrates have previously been shown to favour cell interactions, enhance osseointegration and 
bone formation in vivo. Moreover, such thin films have enough mechanical strength to endure 
clinically relevant shear forces.64 When such properties are combined with the antibacterial 
effect introduced by AMPs, it makes it an ideal candidate for use as bioactive antibacterial 
implant coatings. The F127 hydrogels on the other hand, possesses characteristics such as 
softness and high liquid absorption capacity and can maintain moisture in their structure. Such 
property is an important prerequisite of a wound dressing for a proper wound healing and 
soothing effect.85,86  Hydrogels with such properties were therefore used in this thesis for AMP 
immobilization to develop contact killing surfaces suitable for wound-care application. The 
amphiphilic structures of hydrogels are speculated to be an ideal property to improve the 
stability of immobilized AMPs, since hydrophobic interaction between hydrophobic sites in 
hydrogel structure and hydrophobic domains of AMP molecules can help to form a stronger 
attachment. This speculation is based on Lukas Boge’s work where it was demonstrated that 
AMPs can be immobilized within LLCs (in this case cubosomes) even without covalent 
attachment.87 
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SEM images of dried ELP coatings demonstrate a uniform coating on the microscale with 
porous structure in the nanoscale formed on Ti surfaces as shown in Figure 20b.  
 
 
 
 
Figure 20. a, Proposed schematic model for conjugation of ELP onto Ti substrates using 
diarizine moiety. b, SEM of photocrosslinked ELP onto Ti substrate, the magnification 
increases from left to right. 
 
The amphiphilic domains of the hydrogel are arranged in an ordered structure consisting of 
alternating hydrophilic and hydrophobic domains.88 The SAXS data obtained from the hydrogel 
structures have shown highly ordered mesoscale structure of hydrogels indicating that lyotropic 
liquid crystals have preserved their order after cross-linking throughout the gel.70,76 Figure 21 
is a photo taken from a 3D printed hydrogel mesh before and after water absorption (swelling). 
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Figure 21. 3D printed hydrogel mesh a) before and b) after water absorption. 
 
The EDC-NHS coupling is shown in Figure 22. According to XPS results shown in Table 2, 
EDC-NHS immobilization of the AMP, RRPRPRPRPWWWW-NH2 did not introduce any 
impurities to ELP coatings before and after attachment.  
RRPRPRPRPWWWW-NH2, is a cationic peptide rich in proline and arginine amino acids that 
provide positive charge, and a hydrophobic tryptophan (W) rich tail. The  positive net charge 
facilitates bonding to the negatively charged phospholipid head groups of bacteria membranes 
while the hydrophobic W tail is believed to limit the toxicity of the AMP to eukaryotic cells 
and allow deeper penetration into the interfacial region of negatively charged membranes.53,89–
91  
  
 
Figure 22. A demonstration of AMP binding onto substrates (ELP coatings/ F127 hydrogels) 
by EDC/NHS activation. 
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Table 2. The atomic percentage (%) of the chemical composition of ELP thin films coated on 
Ti discs before and after AMP conjugation by EDC/NHS coupling, as measured by XPS. 
 C1s N1s O1s Ti2P 
Titanium disk 0.75 0.29 55.80 43.16 
ELP coated Ti 64.20 15.71 20.09 - 
ELP Coated Ti + AMP 51.98 16.88 31.14  
 
 
QCM-D measurements were performed to investigate the stability of covalently bonded 
antimicrobial peptide into ELP substrates in comparison to when they are only physically 
adsorbed onto the ELP thin films. Considerably more AMPs were attached onto EDC/NHS 
activated ELP surfaces compared to non-activated surfaces, as shown in Figure 23. The same 
trend was observed on the activated and non-activated Ti surfaces. However, the AMP amount 
bound to Ti surfaces after EDC/NHS activation was significantly lower. Upon rinsing with 
Milli-Q water, most of the AMP remained on the activated ELP surface while the whole content 
of AMPs was released from the other surfaces. These results confirm a stable attachment of 
AMP onto ELP surfaces via the EDC/NHS coupling approach.  
 
Figure 23. QCM-D results obtained from loading and washing AMP onto ELP surfaces with 
and without EDC-NHS activation. Pure Ti surfaces were used as control. 
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As a proof to show that covalently attached AMPs are not leached out from hydrogel substrates, 
a zone inhibition test was performed using S. aureus. A visible inhibition zone around hydrogels 
with physically loaded AMPs was detected as shown in Figure 24.  Such zone is a result of 
bacterial eradication around the hydrogel due to release of physically bonded AMPs into the 
BHI agar plate surface. No inhibition zone was found around hydrogels with covalently bonded 
AMPs. Such property is very important to create contact killing surfaces to preserve their 
antibacterial effect for a longer time. 
 
Figure 24. Images of the three different types of hydrogels when grown on BHI agar plate 
streaked with S.aureus in its log phase. From left to right is the hydrogel, the physically 
adsorbed AMP-hydrogel and lastly the covalently attached AMP-hydrogel.  
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6.2.2 Antibacterial performance of contact-killing surfaces 
 
Both types of contact killing substrates developed in this thesis showed high antimicrobial 
efficacy against S. epidermidis, S. aureus and P. aeruginosa. Moreover, AMP-hydrogels even 
showed to be very effective towards two resistant strains of bacteria MRSA and MDR E. coli. 
The images of live and dead bacteria obtained by fluorescent microscopy shown in Figures 25 
and 27, show a high population of dead cells on surfaces with covalently attached AMPs 
compared to the ones without AMP. The statistical data show significant increase in the dead 
population of bacteria, including the resistant types on AMP treated surfaces, Figure 26, 28 and 
29. 
 
 
Figure 25. Images of biofilms formed onto ELP thin films with and without AMP. The bacteria 
are stained with SYTO® 9 and propidium iodide. The live bacteria appear green and the dead 
bacteria appear red. a, S. epidermidis b, S. aureus and c, P. aeruginosa. 
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Figure 26. Data from analyzing the live and dead fractions of biofilms formed on ELP surfaces 
with and without AMP. The values are obtained from analyzing fluorescent images. Values are 
mean ±SD, N=3. 
 
Figure 27. Images of biofilms formed onto AMP-hydrogels with and without AMP. The 
bacteria were stained by SYTO® 9 and propidium iodide. The live bacteria appear green and 
the dead bacteria appear red. a, S. epidermidis b, S. aureus and c, P. aeruginosa e, MRSA f, 
MDR E. coli. 
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Figure 28. Data from analyzing the live and dead fractions of bacterial colonization on AMP-
hydrogel surfaces with and without AMP attachment. The values are obtained from analyzing 
fluorescent images using ImageJ software. Values are mean ±SD, NC3, *p<0.05. 
 
 
Figure 29. Data from analyzing the live and dead fractions of resistance bacteria a, MRSA and 
b, MDR-E. Coli formed on AMP-hydrogel surfaces with and without AMP attachment. The 
values are obtained from analyzing fluorescent images using Image J software. Values are 
mean ±SD, N=3, *p<0.05  
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The morphology of bacteria attached to AMP-elastin surfaces was evaluated using SEM and as 
shown in the micrographs in Figure 30, all types of bacteria underwent changes in their shapes 
and morphology when attached to AMP treated surfaces. The overall results imply that the 
interaction of AMP with the bacteria surface causes a physical deformation of bacteria that 
leads to their death.  
 
 
Figure 30. SEM images of bacteria taken after 24h a, S. epidermidis b, S. aureus and c, P. 
aeruginosa. The magnification increases from left to right. The pictures on the top row are the 
biofilms formed on ELP surfaces and the bottom row shows the bacteria grown on AMP 
functionalized ELP surfaces. 
 48 
 
 
 
6.2.3 Assessment of stability of covalently attached peptides 
 
One of the major obstacles to overcome in using AMPs clinically is their inherently low stability 
towards degradation.54 This property can explain why AMPs that exhibit significant bacterial 
effect in vitro, do not act as effectively in vivo. Often high concentration of AMPs is used to 
compensate for their low in vivo activity which leads to an increase of their systemic 
cytotoxicity. To investigate whether covalent immobilization of peptides affect their half-life 
the stability of covalently bonded peptides in serum was investigated. This serum-based model 
was chosen since it has been reported that the in vitro stability in serum or plasma is a 
representative model for their in vivo bioavailability.92 Fluorescently labelled peptides 
immobilized on ELP surfaces were seen to aggregate and detach from the surfaces after 24h 
when subjected to serum as shown in Figure 31.  This is while the serum stability of the same 
analogues of peptides with short tryptophan and arginine rich sequences showed a half live of 
< 0.5h-6.5h.92 The serum stability results corresponded well with bacterial assays where the 
AMP modified elastin substrates showed high bacterial killing effect up to 24h and the effect 
was lost at 48h (Figure 32). The loss of AMP activity in serum can be attributed to the presence 
of other proteins and enzymes in the serum. The peptides rich in cationic components are more 
susceptible to degradation since the charged components in their structure such as arginine and 
lysine content, expose a higher number of cleavage sites to degrading enzymes.93  
Similar results were achieved for AMP-hydrogel surfaces. From the results of the bacterial 
assays shown in Figure 33, the peptides show high antibacterial activity against S. aureus for 
48h. Considering an infection-preventive wound patch made of AMP-hydrogel, a 48h 
antibacterial activity can be enough to eradicate bacteria present in the wound during early 
process of wound healing. 
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Figure 31. Fluorescence microscopy images of 5(6) Carboxyfluorescein tagged 
RRPRPRPRPWWWW-NH2 immobilized onto ELP surfaces treated in 20% human blood 
serum at different duration of time. Milli-Q water treated peptides was used as control.  
(S= 20% serum media, W= Milli-Q water media)            
 
 
Figure 32. Bacteria (S. epidermidis) response to AMP functionalized surfaces treated in 20% 
serum at different duration of time. 
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Figure 33. The proportion of dead cells (S. aureus) on hydrogel surfaces with and without 
AMP, incubated up to 2 days in 20% human serum. The data calculated by images from 
live/dead staining at each time point. Values are mean ±SD, N=3, *p<0.05.  
 
6.2.4 In vivo and toxicity assessments 
 
A pilot in vivo study was performed to acquire knowledge of the antibacterial activity and 
performance of AMP-hydrogels in a rat-model. Two dosages of bacterial inoculation (104 and 
2x106 CFU) were used and viability and CFU counting were obtained from retrieved implants 
and the exudates at two different time points (24h and 72h). The CFU results are presented in 
Figure 34, showing 10-100x higher numbers of CFUs from hydrogels without AMP compared 
to AMP-hydrogels for both inoculums at 24h and 72h. Although the difference was larger for 
24h than for 72h. Over time, there was a clear increase in CFUs from AMP-hydrogel implants. 
This corresponds well to our previous in vitro experiments where a significant loss of AMP 
activity was found after 48h. Therefore, after 72h the AMPs might have lost some of their 
activity. CFUs from AMP-hydrogel exudates were not significantly different over time. 
However, the amount of CFU in exudates from hydrogels with and without AMP differed with 
different time points and inoculum sizes and did not follow any regular pattern. In the tests 
performed at 104 CFU dose, a decrease in CFU count was observed for 72h and for 106 CFU 
dose, the same behaviour occurred at 24h.  
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Overall, considering the results from retrieved hydrogels in pilot in vivo study, there was a clear 
decrease in the number of bacteria attached to AMP-hydrogels compared to those without 
AMPs. However, a more comprehensive in vivo study with a model that more closely resembles 
an infected wound is needed to confirm the efficacy of AMP-hydrogels. 
 
 
 
Figure 34. The amount of CFU adhering to the hydrogels and present in exudates at 24h and 
72h inoculated with a, 104 and b, 2x106 CFU dose.  (Arrow: Not countable, but more than 
corresponding test disk and similar to same dilution at 72h)  
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The viability of human bone marrow-derived mesenchymal stem cells (hMSCs) on ELP 
surfaces modified by AMP immobilization was studied by live/dead imaging using fluorescent 
microscopy. There were no visible changes in the viability of the cells adhered to ELP surfaces 
after AMP immobilization (Figure 35). These data indicate that introducing AMPs onto ELP 
surfaces via covalent immobilization, did not disturb the cell-adhesivity to the substrates and 
showed no toxicity to the mammalian cells used. 
 
 
 
Figure 35. Live/Dead imaging of hMSCs cells on ELP surfaces coated on Ti discs with and 
without AMP modification. Cells are stained with calcein AM (live stain, green) and ethidium 
homodimer (dead stain, red). 
 
Moreover, it was shown that the AMPs attached to hydrogel surfaces did not affect the viability 
of fibroblasts studied by MTT assays, Figure 36. The results suggest that while the presence of 
AMPs on the hydrogel introduced a high bacterial killing effect, it did not add any toxicity to 
human-derived cells used in this study (more than 70% cell viability). Such property makes the 
AMP-hydrogel a suitable selective antibacterial surface to be used for prevention of bacterial 
infection in wound management without harming host tissue cells. 
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Figure 36. The cell viability obtained by two MTT assays performed on fibroblast with media 
exposed to control and test samples. The red line indicates 75% cell viability. Samples that are 
higher than this is regarded as non-toxic. The hydrogels analyzed were the control and the 
covalently attached AMPs, with 2x4 hydrogels each. Both different kind of samples showed a 
significantly higher cell viability than the 75% cut-off. 
 
 
It has previously been shown that ELP coatings can promote mineralization of hMSCs on Ti 
surfaces.64 To assess if AMP modification can affect the early-stage osteogenic differentiation 
of hMSCs on ELP-coated substrates, alkaline phosphatase (ALP) activity was quantified. The 
results shown in Figure 37a, imply that the presence of AMPs on ELP surfaces does not interfere 
with the early onset of ELP-induced differentiation of hMSCs.   
Calcium deposition, which is known to occur after ALP activation, showed no statistically 
significant differences across all surfaces tested. Both AMP-treated surfaces showed similar 
calcium deposition to non-treated ELP and bare titanium surfaces, hence the mineralization on 
the surfaces was not affected by the presence of AMPs (Figure 37b).  The overall conclusion is 
that AMP modification does not interfere with the osseointegrative properties of ELP-coated 
surfaces over 28 days in vitro.  
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Figure 37. a, ALP activity of hMSCs seeded onto bare Ti or ELP substrates with 0, 20, or 200 
M of AMP. ALP activity is normalized to DNA concentration. b, Total calcium deposition of 
hMSCs seeded onto substrates. Values are mean ±SD, *p<0.05. 
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For a proper wound management, the control of bleeding is a vital factor that involves the 
formation of a fibrin clot in the wound in which platelets are trapped and release inflammatory 
chemokines to initiate the healing processes.94 That stage will create lateral responses to activate 
inflammatory responses and subsequent wound healing.95 Therefore we investigated how the 
presence of AMPs in the hydrogels can affect the blood coagulation. Fresh whole blood from 2 
different donors were used in the experiments, where the number of platelets were quantified 
before and after 1h of exposure to the hydrogels. A clearly visible clot formation was observed 
onto AMP-hydrogel compared to the ones without AMP, shown in Figure 37b. As expected 
from the observations, the results from platelet counting (shown in Figure 38a) showed 
significantly lower number of platelets in the presence of AMPs. The results suggest that using 
AMP-hydrogel as a wound patch can accelerate blood coagulation and clot formation on a 
bleeding wound. This can be considered as a desired additional property introduced by AMP-
hydrogels apart from the superior antibacterial effect. 
 
 
Figure 38. a, number of platelets after whole blood incubation at 37° for 60 min. Data 
represents mean ±SD, N=4, *p<0.05 and b, photo from appearance of the hydrogels after 1h 
blood contact.  
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7 Conclusions 
 
Antibacterial surfaces are promising solutions for early prevention of biomaterial associated 
infection and to decrease the bioburden in a contaminated wound post-surgery.  
In this thesis, the design and performance of two categories of antibacterial surfaces were 
introduced and discussed. We developed an antibiotic releasing substrate using mesoporous 
titania thin films. MPT thin films with pore sizes of 4, 6 and 7 nm were successfully synthesised 
and loaded with antibiotics. Antimicrobial behaviour of all surfaces was improved by 
antibacterial loading and the effect correlated well with the amount of antibiotic released from 
each substrate. By combining with an additional thin film made of a thermo-responsive polymer 
(PNIPAAm) with incorporated gold nanorods, we created a photon-induced drug-delivery 
coating that could induce the initial drug release using NIR irradiation and observed a desired 
property in inhibition of bacterial growth. 
In a separate approach, we fabricated and evaluated contact killing surface coatings. AMPs 
were successfully immobilized onto ELP and F127 hydrogel substrates using EDC-NHS 
chemistry and the functionalized surfaces showed high bacterial killing efficacy against various 
strains of bacteria including resistant types as well as no toxicity to human-derived cells. 
Stability of covalent immobilized AMPs was shown to be improved compared to AMPs in free 
state. 
The work that has been performed and presented in this thesis, suggest useful strategies for 
development of antibacterial coatings for biomedical applications with an aim to decrease 
overall usage of antibiotic for treatment and prevention of BAI and post implantation surgery 
wounds. The hope is that these approaches can be shaped and adapted further for designing 
functional antibacterial medical devices and implants to bring practical benefits for patients in 
need and most importantly help to fight antibiotic resistance worldwide.   
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